Pictured: Suzanne Wolden

Suzanne L. Wolden, MD, FACR

Radiation Oncologist

Clinical Expertise

Pediatric Radiation Oncology; Pediatric Sarcomas & Blood Cancers; Pediatric Brain Tumors; Intensity Modulated Radiation Therapy; Image-Guided Radiation Therapy; Intra-Operative Radiation Therapy; Proton Therapy

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Wolden accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me

Education

MD, University of California San Francisco

Residencies

Radiation Oncology - Stanford University Medical Center

Board Certifications

Radiation Oncology

I am a board-certified radiation oncologist who cares for children and young adults with cancer. I am a member of the pediatric, ophthalmic, and bone marrow transplant disease management teams, and work very closely with surgeons and medical oncologists in these specialties.

I have extensive experience treating rare diseases in young people such as sarcomas, brain tumors, neuroblastoma, Wilms’ tumor, lymphoma, and leukemia. Radiation therapy is an extremely powerful tool for these tumors, but young patients are especially sensitive to long-term side effects. I therefore approach each patient as a unique individual, carefully designing a highly customized radiation therapy plan to maximize the benefits of treatment while minimizing side effects. I am a leader in the use of targeted approaches such as proton therapy, intensity-modulated radiation therapy, image-guided radiation therapy, and intra-operative radiation therapy for pediatric cancers.

In the Brain Tumor Center, I treat all children and teenagers with cancers of the brain and spinal cord (central nervous system). My clinical research has led to changes in our approach to the treatment of tumors such as medulloblastoma and central nervous system germ cell tumors. We are very mindful of patients’ long-term quality of life and seek to maintain the highest possible survival rates while minimizing the risk of potential long-term treatment complications.

I am involved in numerous clinical trials and oversee large international studies for the Children’s Oncology Group in the areas of soft tissue sarcoma and Hodgkin lymphoma. I am involved with research on the late effects of radiation therapy through my collaboration with the Childhood Cancer Survivor Study.

I find it very rewarding to work with a team that couples extraordinary experience with compassion to care for patients with cancer. I am optimistic that our ongoing research will lead to higher cure rates as well as improved long-term quality of life for our patients.

I find it very rewarding to work with a team that couples extraordinary experience with compassion to care for patients with cancer.

Dr. Wolden

Awards and Honors

  • Castle Connolly: New York Magazine Top Doctors (2014-2018)

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Wolden’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.